| 1 |
33332934 | Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells. | 2021 Jul |
1 |
| 2 |
32709004 | Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting. | 2020 Jul 17 |
1 |
| 3 |
30871186 | Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types. | 2019 Mar 13 |
1 |
| 4 |
25017803 | Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer. | 2014 Sep |
3 |
| 5 |
25558828 | A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells. | 2014 |
1 |
| 6 |
23565244 | PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells. | 2013 |
1 |
| 7 |
20371688 | Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors. | 2010 Apr 15 |
2 |